Fine-Tuning Translation Kinetics Selection as the Driving Force of Codon Usage Bias in the Hepatitis A Virus Capsid
Hepatitis A virus (HAV), the prototype of genus Hepatovirus, has several unique biological characteristics that distinguish it from other members of the Picornaviridae family. Among these, the need for an intact eIF4G factor for the initiation of translation results in an inability to shut down host protein synthesis by a mechanism similar to that of other picornaviruses. Consequently, HAV must inefficiently compete for the cellular translational machinery and this may explain its poor growth in cell culture. In this context of virus/cell competition, HAV has strategically adopted a naturally highly deoptimized codon usage with respect to that of its cellular host. With the aim to optimize its codon usage the virus was adapted to propagate in cells with impaired protein synthesis, in order to make tRNA pools more available for the virus. A significant loss of fitness was the immediate response to the adaptation process that was, however, later on recovered and more associated to a re-deoptimization rather than to an optimization of the codon usage specifically in the capsid coding region. These results exclude translation selection and instead suggest fine-tuning translation kinetics selection as the underlying mechanism of the codon usage bias in this specific genome region. Additionally, the results provide clear evidence of the Red Queen dynamics of evolution since the virus has very much evolved to re-adapt its codon usage to the environmental cellular changing conditions in order to recover the original fitness.
Vyšlo v časopise:
Fine-Tuning Translation Kinetics Selection as the Driving Force of Codon Usage Bias in the Hepatitis A Virus Capsid. PLoS Pathog 6(3): e32767. doi:10.1371/journal.ppat.1000797
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1000797
Souhrn
Hepatitis A virus (HAV), the prototype of genus Hepatovirus, has several unique biological characteristics that distinguish it from other members of the Picornaviridae family. Among these, the need for an intact eIF4G factor for the initiation of translation results in an inability to shut down host protein synthesis by a mechanism similar to that of other picornaviruses. Consequently, HAV must inefficiently compete for the cellular translational machinery and this may explain its poor growth in cell culture. In this context of virus/cell competition, HAV has strategically adopted a naturally highly deoptimized codon usage with respect to that of its cellular host. With the aim to optimize its codon usage the virus was adapted to propagate in cells with impaired protein synthesis, in order to make tRNA pools more available for the virus. A significant loss of fitness was the immediate response to the adaptation process that was, however, later on recovered and more associated to a re-deoptimization rather than to an optimization of the codon usage specifically in the capsid coding region. These results exclude translation selection and instead suggest fine-tuning translation kinetics selection as the underlying mechanism of the codon usage bias in this specific genome region. Additionally, the results provide clear evidence of the Red Queen dynamics of evolution since the virus has very much evolved to re-adapt its codon usage to the environmental cellular changing conditions in order to recover the original fitness.
Zdroje
1. GranthamR
GautierC
GouyM
MercierR
PaveA
1980 Codon catalog usage and the genome hypothesis. Nucl Acids Res 8 197 19c
2. GranthamR
GautierC
GouyM
1980 Codon frequencies in 119 individual genes confirm corsistent choices of degenerate bases according to genome type. Nucl Acids Res 8 1893 1912
3. IkemuraT
1981 Correlation between the abundance of Escherichia coli transfer RNAs and the occurrence of the respective codons in its protein genes. J Mol Biol 146 1 21
4. BennetzenJL
HallBD
1982 Codon selection in yeast. J Biol Chem 257 3026 3031
5. MoriyamaEN
PowellJR
1997 Codon Usage Bias and tRNA Abundance in Drosophila. J Mol Evol 45 514 523
6. StenicoM
LloydAT
SharpPM
1994 Codon usage in Caenorhabditis elegans: delineation of translational selection and mutational biases. Nucl Acids Res 22 2437 2446
7. ChiapelloH
LisacekF
CabocheM
AlainH
1998 Codon usage and gene function are related in sequences of Arabidopsis thaliana. Gene 209 GC1 GC38
8. MustoH
CruveillerS
D'OnofrioG
RomeroH
BernardiG
2001 Translational Selection on Codon Usage in Xenopus laevis. Mol Biol Evol 18 1703 1707
9. UrrutiaAO
HurstLD
2001 Codon Usage Bias Covaries With Expression Breadth and the Rate of Synonymous Evolution in Humans, but This Is Not Evidence for Selection. Genetics 159 1191 1199
10. SemonM
LobryJR
DuretL
2006 No Evidence for Tissue-Specific Adaptation of Synonymous Codon Usage in Humans. Mol Biol Evol 23 523 529
11. ChamaryJV
HurstL
2005 Evidence for selection on synonymous mutations affecting stability of mRNA secondary structure in mammals. Genome Biol 6 R75
12. ChamaryJV
HurstLD
2005 Biased codon usage near intron-exon junctions: selection on splicing enhancers, splice-site recognition or something else? Trends Genet 21 256 259
13. ParmleyJL
ChamaryJV
HurstLD
2006 Evidence for Purifying Selection Against Synonymous Mutations in Mammalian Exonic Splicing Enhancers. Mol Biol Evol 23 301 309
14. PlotkinJB
RobinsH
LevineAJ
2004 Tissue-specific codon usage and the expression of human genes. Proc Natl Acad Sci USA 101 12588 12591
15. LavnerY
KotlarD
2005 Codon bias as a factor in regulating expression via translation rate in the human genome. Gene 345 127 138
16. KomarAA
LesnikT
ReissC
1999 Synonymous codon substitutions affect ribosome traffic and protein folding during in vitro translation. FEBS Lett 462 387 391
17. Kimchi-SarfatyC
OhJM
KimIW
SaunaZE
CalcagnoAM
2007 A “Silent” Polymorphism in the MDR1 Gene Changes Substrate Specificity. Science 315 525 528
18. YangZ
NielsenR
2008 Mutation-Selection Models of Codon Substitution and Their Use to Estimate Selective Strengths on Codon Usage. Mol Biol Evol 25 568 579
19. dos ReisM
SavvaR
WernischL
2004 Solving the riddle of codon usage preferences: a test for translational selection. Nucleic Acids Res 32 5036 5044
20. KarlinS
BlaisdellBE
SchachtelGA
1990 Contrasts in codon usage of latent versus productive genes of Epstein-Barr virus: data and hypotheses. J Virol 64 4264 4273
21. ZhouJ
LiuWJ
PengSW
SunXY
FrazerI
1999 Papillomavirus Capsid Protein Expression Level Depends on the Match between Codon Usage and tRNA Availability. J Virol 73 4972 4982
22. BurnsCC
ShawJ
CampagnoliR
JorbaJ
VincentA
2006 Modulation of Poliovirus Replicative Fitness in HeLa Cells by Deoptimization of Synonymous Codon Usage in the Capsid Region. J Virol 80 3259 3272
23. SanchezG
BoschA
PintoRM
2003 Genome variability and capsid structural constraints of hepatitis a virus. J Virol 77 452 9
24. ColemanJR
PapamichailD
SkienaS
FutcherB
WimmerE
2008 Virus Attenuation by Genome-Scale Changes in Codon Pair Bias. Science 320 1784 1787
25. BuchanJR
AucottLS
StansfieldI
2006 tRNA properties help shape codon pair preferences in open reading frames. Nucl Acids Res 34 1015 1027
26. RacanielloVR
2001 Picornaviridae: The viruses and their replication.
FieldsBN
KnipeDM
HowleyPM
GriffinDE
Fields' virology Philadelphia, Pa Lippincott Williams & Wilkins 685 722
27. AliIK
McKendrickL
MorleySJ
JacksonRJ
2001 Activity of the Hepatitis A Virus IRES Requires Association between the Cap-Binding Translation Initiation Factor (eIF4E) and eIF4G. J Virol 75 7854 7863
28. WhetterLE
DaySP
ElroysteinO
BrownEA
LemonSM
1994 Low efficiency of the 5' nontranslated region of hepatitis A virus RNA in directing cap-independent translation in permissive monkey kidney cells. J Virol 68 5253 5263
29. PintoRM
AragonesL
CostafredaMI
RibesE
BoschA
2007 Codon usage and replicative strategies of hepatitis A virus. Virus Res 127 158 163
30. AragonesL
BoschA
PintoRM
2008 Hepatitis A Virus Mutant Spectra under the Selective Pressure of Monoclonal Antibodies: Codon Usage Constraints Limit Capsid Variability. J Virol 82 1688 1700
31. ReichE
FranklinRM
ShatkinAJ
Tatumel
1962 Action of actinomycin D on animal cells and viruses. Proc Natl Acad Sci USA 48 1238 1245
32. DomingoE
MartinV
PeralesC
Grande-PerezA
Garcia-ArriazaJ
2006 Viruses as quasispecies: biological implications. Curr Top Microbiol Immunol 299 51 82
33. SanchezG
BoschA
Gomez-MarianoG
DomingoE
PintoRM
2003 Evidence for quasispecies distributions in the human hepatitis A virus genome. Virology 315 34 42
34. MuellerS
PapamichailD
ColemanJR
SkienaS
WimmerE
2006 Reduction of the Rate of Poliovirus Protein Synthesis through Large-Scale Codon Deoptimization Causes Attenuation of Viral Virulence by Lowering Specific Infectivity. J Virol 80 9687 9696
35. GellerR
VignuzziM
AndinoR
FrydmanJ
2007 Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractory to development of drug resistance. Genes Dev 21 195 205
36. Ruiz-JaraboCM
AriasA
BaranowskiE
EscarmisC
DomingoE
2000 Memory in Viral Quasispecies. J Virol 74 3543 3547
37. KrakauerDC
JansenVA
2002 Red queen dynamics of protein translation. J Theor Biol 218 97 109
38. de KokJB
RoelofsRW
GiesendorfBA
PenningsJL
WaasET
2004 Normalization of gene expression measurements in tumor tissues: comparison of 13 endogenous control genes. Lab Invest 85 154 159
39. VandesompeleJ
De PreterK
PattynF
PoppeB
Van RoyN
2002 Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3 0034.1 0034.11
40. Ramos-NinoME
ScapoliL
MartinelliM
LandS
MossmanBT
2003 Microarray Analysis and RNA Silencing Link fra-1 to cd44 and c-met Expression in Mesothelioma. Cancer Res 63 3539 3545
41. PfrunderA
GutmannH
BeglingerC
DreweJ
2003 Gene expression of CYP3A4, ABC-transporters (MDR1 and MRP1-MRP5) and hPXR in three different human colon carcinoma cell lines. J Pharm Pharmacol 55 59 66
42. SanchezG
PintoRM
VanaclochaH
BoschA
2002 Molecular characterization of hepatitis a virus isolates from a transcontinental shellfish-borne outbreak. J Clin Microbiol 40 4148 55
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 3
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Kaposi's Sarcoma-Associated Herpesvirus ORF57 Protein Binds and Protects a Nuclear Noncoding RNA from Cellular RNA Decay Pathways
- Endocytosis of the Anthrax Toxin Is Mediated by Clathrin, Actin and Unconventional Adaptors
- Perforin and IL-2 Upregulation Define Qualitative Differences among Highly Functional Virus-Specific Human CD8 T Cells
- Inhibition of Macrophage Migration Inhibitory Factor Ameliorates Ocular -Induced Keratitis